Dr. Kaspar Trocha, MD

Dr. Trocha practices at The San Francisco Vein and Vascular Institute, LLC in San Francisco, California.

Dr. Trocha's NPI, 1245670694, was assigned on June 30, 2013. Dr. Trocha graduated from University of Medical Science Poznan in 2013. Dr. Trocha's New Jersey license number on file is 25MA11201700.

Dr. Trocha's primary practice is The San Francisco Vein and Vascular Institute, LLC, at 2250 Hayes St, San Francisco, CA 94117 in San Francisco County. The practice phone is (415) 221-7056.

Dr. Trocha's primary practice is The San Francisco Vein and Vascular Institute, LLC in San Francisco, California. Dr. Trocha is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is BASS Medical Group. Dmand AI also links Dr. Trocha to 3 more hospitals, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trocha practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Trocha's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Trocha's licenses on file in 2 states: New Jersey and California.

CMS data shows 319 Medicare services from Dr. Trocha across 7 procedure codes in 2024, for 282 Medicare patients. Medicare paid $19,001 for them.

CMS counts 282 Medicare patients who saw Dr. Trocha in 2024. The largest group is 75 to 84, with 122 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trocha's median patient age at 68, with 50% women.

In 2024, Dr. Trocha wrote 45 Medicare Part D claims for 14 patients. 98% of them were for generic drugs. CMS names the drug for 26 of them, across 1 drug with 11 or more claims each, at $120 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Trocha for performance year 2024, reported as part of a group. Dr. Trocha accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Trocha, published from 2018 to 2022. 2021 was the busiest year, with 5. The most frequent topics are Diet, Protein-Restricted, Disease Models, Animal and Mice, Inbred C57BL. Dr. Trocha has published most often in Ann Vasc Surg. Dr. Trocha's most frequent co-authors are C Keith Ozaki, MD, Alban Etienne Pierre Longchamp and James R. Mitchell, MD.

CMS Open Payments shows 50 general payments to Dr. Trocha from 14 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 56% of the total. Boston Scientific Corporation paid the most, $2,109.

Dr. Trocha graduated from University of Medical Science Poznan in 2013.

Dr. Trocha is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.